Cargando…
Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes
We hypothesized that sphingolipids may be early biomarkers of gestational diabetes mellitus (GDM). Here, 520 women with normal fasting plasma glucose levels were recruited in the first trimester and tested with a 75 g oral glucose tolerance test in the 24th–28th week of pregnancy. Serum sphingolipid...
Autores principales: | Juchnicka, Ilona, Kuźmicki, Mariusz, Zabielski, Piotr, Krętowski, Adam, Błachnio-Zabielska, Agnieszka, Szamatowicz, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781005/ https://www.ncbi.nlm.nih.gov/pubmed/35054078 http://dx.doi.org/10.3390/jcm11020384 |
Ejemplares similares
-
miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus
por: Juchnicka, Ilona, et al.
Publicado: (2022) -
Ceramides and Sphingosino-1-Phosphate in Obesity
por: Juchnicka, Ilona, et al.
Publicado: (2021) -
CerS1 but Not CerS5 Gene Silencing, Improves Insulin Sensitivity and Glucose Uptake in Skeletal Muscle
por: Błachnio-Zabielska, Agnieszka U., et al.
Publicado: (2022) -
Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?
por: Sobota-Grzeszyk, Angelika, et al.
Publicado: (2019) -
Ceramide Content in Liver Increases Along with Insulin Resistance in Obese Patients
por: Razak Hady, Hady, et al.
Publicado: (2019)